HBV vaccine (Newsummit/Seoul National University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHBV vaccine (Newsummit/Seoul National University)
Drug Alias Namehepatitis B virus vaccine (Newsummit/Seoul National University)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSeoul National University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeoul National UniversityShanghai Xinshengyuan Biological Medicine Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A